TransMedics Group, Inc. (TMDX)

NASDAQ: TMDX · Real-Time Price · USD

72.26

+1.13 (1.59%)

Jul 24, 2026, 4:00 PM EDT - Market closed

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 28, 2019	Dec '18 Dec 29, 2018	Dec '17 Dec 30, 2017	Dec '16 Dec 31, 2016
United States Lung Revenue	12.00M	13.44M	15.76M
United States Heart Revenue	111.43M	111.84M	96.66M
United States Liver Revenue	489.67M	459.42M	309.46M
United States OCS Transplant Revenue	613.10M	584.70M	421.88M
All Other Countries Lung Revenue	1.67M	1.42M	1.93M
All Other Countries Heart Revenue	15.63M	14.17M	13.20M
All Other Countries Liver Revenue	983.00K	1.11M	158.00K
All Other Countries OCS Transplant Revenue	18.28M	16.70M	15.28M
Total OCS Transplant Revenue	631.39M	601.40M	437.16M
Other Service Revenue	4.50M	4.10M	4.38M
Revenue (Total)	635.89M	605.49M	441.54M

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 28, 2019	Dec '18 Dec 29, 2018	Dec '17 Dec 30, 2017	Dec '16 Dec 31, 2016
Net Product Revenue	392.14M	372.40M	273.87M
Service Revenue	243.75M	233.09M	167.67M
Revenue (Total)	635.89M	605.49M	441.54M